T1	Participants 52 81	colorectal adenoma recurrence
T2	Participants 212 255	colorectal neoplasms in some human studies.
T3	Participants 528 577	1,859 participants of the Polyp Prevention Trial.
T4	Participants 1133 1142	in women.
